Canada markets closed

Canntab Therapeutics Limited (CTABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
At close: 12:12PM EDT
Full screen
Loading interactive chart...
  • CNW Group

    CANNTAB ANNOUNCES CHANGE OF AUDITOR

    Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces that that it has changed its auditor from MNP LLP (the "Former Auditor") to Clearhouse LLP (the "Successor Auditor"). The Former Auditor resigned effective May 27, 2022, at the Company's request, and the Company's board of directors appointed the Successor Auditor to fill the resulting vaca

  • CNW Group

    Canntab Engages Hamish Sutherland as Strategic Advisor

    Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the Company has engaged Mr. Hamish Sutherland as a strategic business consultant to work with Canntab and develop additional sales and distribution channels for the extensive suite of Canntab's products and to assist Canntab in reaching strategic partnerships in the Cannab

  • CNW Group

    CANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITED

    Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the Company has entered into an affiliate agreement (the "Agreement") with OnPharm-United, a 600 plus network of independent pharmacy owners throughout the Province of Ontario. OnPharm-United is dedicated to providing its members with the ability to maintain their in